These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

731 related articles for article (PubMed ID: 16260698)

  • 21. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma.
    Dieckmann KP; Matthies C; Kliesch S
    J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458
    [No Abstract]   [Full Text] [Related]  

  • 22. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
    Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
    J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myths and facts on adjuvant carboplatin for stage I seminoma.
    Aparicio J; Germà JR
    J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
    [No Abstract]   [Full Text] [Related]  

  • 24. Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.
    Pectasides D; Skarlos D; Dimopoulos AM; Farmakis D; Pectasides M; Fountzilas G; Aravantinos G
    Anticancer Res; 2003; 23(5b):4239-44. PubMed ID: 14666633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
    Bruns F; Raub M; Schaefer U; Micke O
    Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rete testis invasion by malignant germ cell tumor and/or intratubular germ cell neoplasia: what is the significance of this finding?
    Vogt AP; Chen Z; Osunkoya AO
    Hum Pathol; 2010 Sep; 41(9):1339-44. PubMed ID: 20573373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of Stage II testicular seminoma over a period of 40 years.
    Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
    Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
    Aparicio J; Maroto P; García Del Muro X; Sánchez-Muñoz A; Gumà J; Margelí M; Sáenz A; Sagastibelza N; Castellano D; Arranz JA; Hervás D; Bastús R; Fernández-Aramburo A; Sastre J; Terrasa J; López-Brea M; Dorca J; Almenar D; Carles J; Hernández A; Germà JR
    Ann Oncol; 2014 Nov; 25(11):2173-2178. PubMed ID: 25210015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
    Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
    Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
    Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann JT; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl CP; Schmoll HJ; Kanz L; Oliver T
    Br J Cancer; 2004 Aug; 91(4):683-7. PubMed ID: 15266338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of stage I seminoma: is it time to change your practice?
    Feldman DR; Bosl GJ
    J Hematol Oncol; 2008 Nov; 1():22. PubMed ID: 18992162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adjuvant treatment for stage I of testicular germ cell tumours].
    Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
    Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term results of multimodality therapy of testicular germ cell tumor].
    Wang JW; Yang L; Wang JY; Qu T; Cai RG; Huang J; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):382-5. PubMed ID: 12921572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
    Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
    Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carboplatin and cyclophosphamide in the treatment of metastatic seminoma.
    Mardiak J; Sálek T; Sycova-Milá Z; Sufliarsky J; Baláz M; Koza I
    Neoplasma; 2000; 47(4):244-7. PubMed ID: 11043830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long term outcome and cost in the management of stage I testicular seminoma.
    Warde P; Gospodarowicz MK; Panzarella T; Chow E; Murphy T; Catton CN; Sturgeon JF; Moore M; Milosevic M; Jewett MA
    Can J Urol; 2000 Apr; 7(2):967-72; discussion 973.. PubMed ID: 11119439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
    Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
    J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.